Vicore Pharma is a biotechnology company that develops and commercializes drugs for the treatment of fibrotic lung diseases.Read more
$ < 1M
Vicore Pharma's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 5.1B. Over the last four quarters, Vicore Pharma's revenue has decreased by 0%. Specifically, in Q4 2018's revenue was $ < 1M; in Q3 2018, it was $ < 1M; in Q2 2018, it was $ < 1M; in Q1 2018, Vicore Pharma's revenue was $ < 1M.